These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity. Giefing M; Winoto-Morbach S; Sosna J; Döring C; Klapper W; Küppers R; Böttcher S; Adam D; Siebert R; Schütze S PLoS One; 2013; 8(12):e84928. PubMed ID: 24376854 [TBL] [Abstract][Full Text] [Related]
23. Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other. Rengstl B; Kim S; Döring C; Weiser C; Bein J; Bankov K; Herling M; Newrzela S; Hansmann ML; Hartmann S PLoS One; 2017; 12(5):e0177378. PubMed ID: 28505189 [TBL] [Abstract][Full Text] [Related]
29. Allelic losses on chromosome 6q25 in Hodgkin and Reed Sternberg cells. Re D; Starostik P; Massoudi N; Staratschek-Jox A; Dries V; Thomas RK; Diehl V; Wolf J Cancer Res; 2003 May; 63(10):2606-9. PubMed ID: 12750286 [TBL] [Abstract][Full Text] [Related]
30. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. Roemer MG; Advani RH; Ligon AH; Natkunam Y; Redd RA; Homer H; Connelly CF; Sun HH; Daadi SE; Freeman GJ; Armand P; Chapuy B; de Jong D; Hoppe RT; Neuberg DS; Rodig SJ; Shipp MA J Clin Oncol; 2016 Aug; 34(23):2690-7. PubMed ID: 27069084 [TBL] [Abstract][Full Text] [Related]
31. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells. Izban KF; Ergin M; Martinez RL; Alkan S Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929 [TBL] [Abstract][Full Text] [Related]
32. [U-HO1. A new cell line derived from a primary refractory classical Hodgkin lymphoma]. Möller P; Mader A; Barth TF; Brüderlein S Pathologe; 2008 Nov; 29 Suppl 2():317-8. PubMed ID: 18820924 [TBL] [Abstract][Full Text] [Related]
33. Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma. Salipante SJ; Adey A; Thomas A; Lee C; Liu YJ; Kumar A; Lewis AP; Wu D; Fromm JR; Shendure J Genes Chromosomes Cancer; 2016 Mar; 55(3):278-87. PubMed ID: 26650888 [TBL] [Abstract][Full Text] [Related]
34. The biology of classical Hodgkin lymphoma. Kosydar S; Ansell SM Semin Hematol; 2024 Aug; 61(4):212-220. PubMed ID: 38824068 [TBL] [Abstract][Full Text] [Related]
35. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs. Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296 [TBL] [Abstract][Full Text] [Related]
36. Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma. Mata E; Fernández S; Astudillo A; Fernández R; García-Cosío M; Sánchez-Beato M; Provencio M; Estévez M; Montalbán C; Piris MA; García JF Blood Cancer J; 2019 Mar; 9(3):34. PubMed ID: 30858359 [No Abstract] [Full Text] [Related]
37. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339 [TBL] [Abstract][Full Text] [Related]
38. Genetic analysis of sorted Hodgkin and Reed-Sternberg cells using comparative genomic hybridization. Ohshima K; Ishiguro M; Ohgami A; Sugihara M; Haraoka S; Suzumiya J; Kikuchi M Int J Cancer; 1999 Jul; 82(2):250-5. PubMed ID: 10389760 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma. Chen R; Herrera AF; Hou J; Chen L; Wu J; Guo Y; Synold TW; Ngo VN; Puverel S; Mei M; Popplewell L; Yi S; Song JY; Tao S; Wu X; Chan WC; Forman SJ; Kwak LW; Rosen ST; Newman EM Clin Cancer Res; 2020 Mar; 26(5):1034-1044. PubMed ID: 31811017 [TBL] [Abstract][Full Text] [Related]
40. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells. Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]